Jacki Easlick, LLC v. Cj Emerald

Court of Appeals for the Federal Circuit·Decided August 14, 2026·No. 24-1538·Unpublished

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit

JACKI EASLICK, LLC, JE CORPORATE LLC, Plaintiffs-Appellants

v.

ACCENCYC US Defendant-Appellee

CJ EMERALD, ET AL.

Defendants

2024-1538, 2024-1826

Appeals from the United States District Court for the Western District of Pennsylvania in No. 2:23-cv-02000- WSS, Judge William S. Stickman, IV.

Decided: August 14, 2026

STANLEY DONALD FERENCE, III, Ference & Associates LLC, Pittsburgh, PA, argued for plaintiffs-appellants. Also represented by BRIAN SAMUEL MALKIN, Rosenbaum & Segall, PC, Long Beach, NY.

TIMOTHY A. DUFFY, Law Office Of Timothy A. Duffy, PC, Lake Forest, IL, argued for defendant-appellee.

2 JACKI EASLICK, LLC v. CJ EMERALD

Before DYK, SCHALL, and PROST, Circuit Judges.

PROST, Circuit Judge.

Jacki Easlick, LLC and JE Corporate LLC (collectively, “Jacki Easlick”) appeal two decisions of the United States District Court for the Western District of Pennsylvania denying their motions for a preliminary injunction and reconsideration of the denial of the motion for preliminary injunction. For the reasons below, we affirm.

BACKGROUND

This appeal concerns Jacki Easlick’s TOTE HANGER® brand handbag hanger hook (“Tote Hanger”), associated with U.S. Design Patent No. D 695,526 (“the D’526 patent ”). The D’526 patent is a design patent for a hook for hanging handbags on closet rods. Jacki Easlick, LLC v. CJ Emerald, No. 2:23-cv-2000, 2024 WL 310125, at *2 (W.D. Pa. Jan. 26, 2024) (“Jacki Easlick I”).

On November 20, 2023, Jacki Easlick filed suit against 67 online sellers in the Western District of Pennsylvania, alleging that the sellers infringed the D’526 patent by selling hooks for hanging handbags. Id. AccEncyc US (“Acc Encyc”), a Chinese company that sold a handbag hanger hook on Amazon (among many other products), was one of those online sellers.

In its complaint and in an ex parte motion, Jacki Easlick requested “(1) a temporary restraining order; (2) an order restraining assets and merchant storefronts; (3) an order to show cause why a preliminary injunction should not issue; and (4) an order authorizing expedited discovery .” Id. That same day, the district court granted Jacki Easlick’s motion for an ex parte temporary restraining order against all defendants. Id.; Amicus Br. 2 (explaining that “[t]his case is a typical ‘Schedule A’ case, where a plaintiff joins together a large number of unrelated online

JACKI EASLICK, LLC v. CJ EMERALD 3

merchants in a single infringement complaint.” and, as is also “typical” of “Schedule A plaintiffs,” Jacki Easlick obtained an ex parte temporary restraining order “before Appellee had notice or could contest Appellants’ allegations”).1 Jacki Easlick subsequently moved for a preliminary injunction . The district court denied the motion as to AccEncyc , finding that Jacki Easlick had failed to establish a likelihood of success on the merits and irreparable harm. Jacki Easlick I, 2024 WL 310125, at *7, 9. The remaining defendants either entered a consent order or faced default judgment. J.A. 20–21. Jacki Easlick then filed a motion for reconsideration of the district court’s denial of the preliminary -injunction motion. See Jacki Easlick, LLC v. CJ Emerald, No. 2:23-cv-2000, 2024 WL 1657843 (W.D. Pa. Apr. 17, 2024) (“Jacki Easlick II”). The district court denied that motion. Id. at *6.

Jacki Easlick timely appealed both denials to this court. We have jurisdiction under 28 U.S.C. § 1292(a)(1) and (c)(1).

DISCUSSION

“The court considers the following four factors in evaluating a motion for a preliminary injunction: (1) whether the moving party has shown a reasonable likelihood of success on the merits; (2) whether the moving party will suffer irreparable harm in the absence of a preliminary injunction ; (3) whether the balance of hardships tips in the moving party’s favor; and (4) the impact of a preliminary injunction on the public interest.” DexCom, Inc. v. Abbott Diabetes Care, Inc., 89 F.4th 1370, 1375 (Fed. Cir. 2024) (cleaned up). “We review the grant or denial of a

1 We received an Amicus brief from several law professors arguing that so-called “Schedule A” cases are legally permissible. The propriety of the “Schedule A” practice is not before us.

4 JACKI EASLICK, LLC v. CJ EMERALD

preliminary injunction under the law of the regional circuit , here the Third Circuit.” FMC Corp. v. Sharda USA, LLC, 145 F.4th 1326, 1330 (Fed. Cir. 2025).

The Federal Circuit has, however, “itself built a body of precedent applying the general preliminary injunction considerations to a large number of factually variant patent cases, and gives dominant effect to Federal Circuit precedent insofar as it reflects considerations specific to patent issues.” Natera, Inc. v. NeoGenomics Lab’ys., Inc., 106 F.4th 1369, 1375 (Fed. Cir. 2024) (cleaned up). “Both the Third Circuit and the Federal Circuit review the district court’s decision to grant or deny a preliminary injunction for an abuse of discretion.” FMC, 145 F.4th at 1330 (citing Natera, 106 F.4th at 1375, and Ferring Pharms., Inc. v. Watson Pharms., Inc., 765 F.3d 205, 210 (3d Cir. 2014)). “An abuse of discretion may arise when the district court made a clear error of judgment in weighing relevant factors, exercised its discretion based upon an error of law, or exercised its discretion based upon clearly erroneous factual findings.” Id. at 1330 (citing Natera, 106 F.4th at 1375).

Separately, “[a]pplying Third Circuit law, we review a district court’s grant or denial of a motion for reconsideration for an abuse of discretion.” Golden Bridge Tech., Inc. v. Apple Inc., 758 F.3d 1362, 1367 (Fed. Cir. 2014).

Jacki Easlick argues that the district court abused its discretion by applying the wrong standard when evaluating the likelihood of success on the merits and by incorrectly concluding that Jacki Easlick had not shown irreparable harm. We address each of those arguments in turn and conclude by addressing the motion for reconsideration .

I

Jacki Easlick’s position that the district court erred in finding no likelihood of success on the merits rests on two

JACKI EASLICK, LLC v. CJ EMERALD 5

arguments: that the district court (1) improperly focused on individual design details in assessing design-patent infringement and (2) failed to consider the prior art. Appellants ’ Br. 14–23.

To determine “whether a design patent has been infringed . . . the court first construes the claim to determine its meaning and scope” and “the fact finder then compares the properly construed claim to the accused design.” Range of Motion Prods., LLC v. Armaid Co., 166 F.4th 981, 988 (Fed. Cir. 2026). “Design patent infringement is a question of fact, which a patentee must prove by a preponderance of the evidence.” Columbia Sportswear N. Am., Inc. v. Seirus Innovative Accessories, Inc., 942 F.3d 1119, 1129 (Fed. Cir. 2019). “A design patent only protects the novel, ornamental features of the patented design.” OddzOn Prods., Inc. v. Just Toys, Inc., 122 F.3d 1396, 1405 (Fed. Cir. 1997).

Courts employ the “ordinary observer” test to compare the patented and accused designs. Egyptian Goddess, Inc. v. Swisa, Inc., 543 F.3d 665, 678 (Fed. Cir. 2008) (en banc). The “ordinary observer” test provides that if, in the eye of an ordinary observer, giving such attention as a purchaser usually gives, two designs are substantially the same, if the resemblance is such as to deceive such an observer, inducing him to purchase one supposing it to be the other, the first one patented is infringed by the other.

Free access — add to your briefcase to read the full text and ask questions with AI

Jacki Easlick, LLC v. Cj Emerald, (Fed. Cir. 2026).

Jacki Easlick, LLC v. Cj Emerald (Jacki Easlick, LLC v. Cj Emerald) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Richardson v. Stanley Works, Inc.
597 F.3d 1288 (Federal Circuit, 2010)
Crocs, Inc. v. International Trade Commission
598 F.3d 1294 (Federal Circuit, 2010)
International Seaway Trading Corp. v. Walgreens Corp.
589 F.3d 1233 (Federal Circuit, 2009)
Gorham Co. v. White
81 U.S. 511 (Supreme Court, 1872)
Altana Pharma AG v. Teva Pharmaceuticals USA, Inc.
566 F.3d 999 (Federal Circuit, 2009)
Abbott Laboratories v. Andrx Pharmaceuticals, Inc.
452 F.3d 1331 (Federal Circuit, 2006)
Blystone v. Horn
664 F.3d 397 (Third Circuit, 2011)
Apple, Inc. v. Samsung Electronics Co., Ltd.
678 F.3d 1314 (Federal Circuit, 2012)
Apple Inc. v. Samsung Electronics Co., Ltd.
695 F.3d 1370 (Federal Circuit, 2012)
Egyptian Goddess, Inc. v. Swisa, Inc.
543 F.3d 665 (Federal Circuit, 2008)
Pharmacy Benefit Managers Antitrust Litigation
582 F.3d 432 (Third Circuit, 2009)
Golden Bridge Technology, Inc. v. Apple Inc.
758 F.3d 1362 (Federal Circuit, 2014)
Ethicon Endo-Surgery, Inc. v. Covidien, Inc.
796 F.3d 1312 (Federal Circuit, 2015)
Lanard Toys Limited v. Dolgencorp LLC
958 F.3d 1337 (Federal Circuit, 2020)
Dexcom, Inc. v. Abbott Diabetes Care, Inc.
89 F.4th 1370 (Federal Circuit, 2024)
Natera, Inc. v. Neogenomics Laboratories, Inc.
106 F.4th 1369 (Federal Circuit, 2024)